Answer:
Explanation:
Personal care homes provide a home for individuals who need assistance with a variety of daily care needs. It is the goal of the personal care home to provide necessary services for individuals to live as independently as possible.
Answer:
Option D (Aversion therapy) is the appropriate choice.
Explanation:
- A type of behavioral treatment that involves aversive manipulation to mitigate or suppress the action of symptoms or conditions, combining harmful behavior or symptoms towards negative stimuli.
- Closely connected with aversive conditioning, another terminology is more often used. See conduct counseling for behavior modification.
Some other alternatives are also not relevant to the current situation presented. So, the solution is indeed the correct version.
Answer:
DO support the person's breathing by administering oxygen or performing rescue breathing. DO administer naloxone. DO put the person in the “recovery position” on the side, if he or she is breathing independently. DO stay with the person and keep him/her warm.
Explanation:
Biotechnology can be safe, but potential risks exist and the danger is vast but biotechnology could help address many global problems, such as climate change and infectious diseases. It could possibly help in many different science fields too. I don’t think it should be banned because it has such a big importance especially that it implications in health and medicine.
Answer: HDLs are antiatherogenic lipoproteins....
Explanation:
The anti-atherogenic effect of HDL occurs, above all, because of its properties to carry lipids, mainly cholesterol esters from peripheral tissues to the liver, which is known as reverse cholesterol transport(RCT). However, other protective actions of HDL, in addition to RCT, have been described in several experimental models and epidemiological studies. These actions include antioxidant protection, mediation of cholesterol efflux, inhibition of the expression of cell adhesion, leukocyte activation, regulation of blood coagulation and platelet activity.
